These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22329422)

  • 1. Quantitative proteome profiling of normal human circulating microparticles.
    Østergaard O; Nielsen CT; Iversen LV; Jacobsen S; Tanassi JT; Heegaard NH
    J Proteome Res; 2012 Apr; 11(4):2154-63. PubMed ID: 22329422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct proteome features of plasma microparticles.
    Jin M; Drwal G; Bourgeois T; Saltz J; Wu HM
    Proteomics; 2005 May; 5(7):1940-52. PubMed ID: 15825151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma microparticle proteome.
    Little KM; Smalley DM; Harthun NL; Ley K
    Semin Thromb Hemost; 2010 Nov; 36(8):845-56. PubMed ID: 21049385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust Label-free, Quantitative Profiling of Circulating Plasma Microparticle (MP) Associated Proteins.
    Braga-Lagache S; Buchs N; Iacovache MI; Zuber B; Jackson CB; Heller M
    Mol Cell Proteomics; 2016 Dec; 15(12):3640-3652. PubMed ID: 27738094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
    Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
    J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of reproducibility in depletion and enrichment workflows for plasma proteomics using label-free quantitative data-independent LC-MS.
    Hakimi A; Auluck J; Jones GD; Ng LL; Jones DJ
    Proteomics; 2014 Jan; 14(1):4-13. PubMed ID: 24167004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free detection of differential protein expression by LC/MALDI mass spectrometry.
    Neubert H; Bonnert TP; Rumpel K; Hunt BT; Henle ES; James IT
    J Proteome Res; 2008 Jun; 7(6):2270-9. PubMed ID: 18412385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
    Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
    J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome.
    Nagaraj N; Mann M
    J Proteome Res; 2011 Feb; 10(2):637-45. PubMed ID: 21126025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exclusion list based label-free proteome quantification approach using an LTQ Orbitrap.
    Muntel J; Hecker M; Becher D
    Rapid Commun Mass Spectrom; 2012 Mar; 26(6):701-9. PubMed ID: 22328225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
    Zolotarjova N; Mrozinski P; Chen H; Martosella J
    J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OFFgel-based multidimensional LC-MS/MS approach to the cataloguing of the human platelet proteome for an interactomic profile.
    Krishnan S; Gaspari M; Della Corte A; Bianchi P; Crescente M; Cerletti C; Torella D; Indolfi C; de Gaetano G; Donati MB; Rotilio D; Cuda G
    Electrophoresis; 2011 Mar; 32(6-7):686-95. PubMed ID: 21337587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of two-dimensional LC-MS with multivariate statistics for comparative analysis of proteomic samples.
    Gaspari M; Verhoeckx KC; Verheij ER; van der Greef J
    Anal Chem; 2006 Apr; 78(7):2286-96. PubMed ID: 16579610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-analytical and analytical issues in the analysis of blood microparticles.
    Yuana Y; Bertina RM; Osanto S
    Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome profiling of peripheral mononuclear cells from human blood.
    Maccarrone G; Rewerts C; Lebar M; Turck CW; Martins-de-Souza D
    Proteomics; 2013 Mar; 13(5):893-7. PubMed ID: 23281267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of analytical and pre-analytical conditions for MALDI-TOF-MS human urine protein profiles.
    Calvano CD; Aresta A; Iacovone M; De Benedetto GE; Zambonin CG; Battaglia M; Ditonno P; Rutigliano M; Bettocchi C
    J Pharm Biomed Anal; 2010 Mar; 51(4):907-14. PubMed ID: 19939598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive comparison of iTRAQ and label-free LC-based quantitative proteomics approaches using two Chlamydomonas reinhardtii strains of interest for biofuels engineering.
    Wang H; Alvarez S; Hicks LM
    J Proteome Res; 2012 Jan; 11(1):487-501. PubMed ID: 22059437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free-flow electrophoresis system for plasma proteomic applications.
    Wildgruber R; Yi J; Nissum M; Eckerskorn C; Weber G
    Methods Mol Biol; 2008; 424():287-300. PubMed ID: 18369870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.